Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.

Doycheva D, Shih G, Chen H, Applegate R, Zhang JH, Tang J.

Transl Stroke Res. 2013 Apr;4(2):171-8. doi: 10.1007/s12975-012-0225-2. Epub 2012 Nov 8.

2.

Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Doycheva DM, Hadley T, Li L, Applegate RL 2nd, Zhang JH, Tang J.

Neurobiol Dis. 2014 Sep;69:192-9. doi: 10.1016/j.nbd.2014.05.024. Epub 2014 May 27.

3.

Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats.

Fathali N, Lekic T, Zhang JH, Tang J.

Intensive Care Med. 2010 Sep;36(9):1602-8. doi: 10.1007/s00134-010-1913-6. Epub 2010 May 12.

4.

G-CSF ameliorates neuronal apoptosis through GSK-3β inhibition in neonatal hypoxia-ischemia in rats.

Li L, Klebe D, Doycheva D, McBride DW, Krafft PR, Flores J, Zhou C, Zhang JH, Tang J.

Exp Neurol. 2015 Jan;263:141-9. doi: 10.1016/j.expneurol.2014.10.004. Epub 2014 Oct 18.

5.

Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats.

Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH.

Brain Res. 2007 May 11;1145:227-38. Epub 2007 Feb 17.

6.
7.

Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice.

Osada T, Watanabe M, Hasuo A, Imai M, Suyama K, Sakai D, Kawada H, Matsumae M, Mochida J.

J Neurosurg Spine. 2010 Oct;13(4):516-23. doi: 10.3171/2010.4.SPINE09973.

PMID:
20887150
8.

The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.

Zhao LR, Piao CS, Murikinati SR, Gonzalez-Toledo ME.

Recent Pat CNS Drug Discov. 2013 Apr;8(1):2-12. Review.

9.

Delayed application of the haematopoietic growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury.

Neubauer V, Wegleiter K, Posod A, Urbanek M, Wechselberger K, Kiechl-Kohlendorfer U, Keller M, Griesmaier E.

Brain Res. 2016 Mar 1;1634:94-103. doi: 10.1016/j.brainres.2015.12.058. Epub 2016 Jan 7.

PMID:
26772988
10.

Long-term effects of enriched environment following neonatal hypoxia-ischemia on behavior, BDNF and synaptophysin levels in rat hippocampus: Effect of combined treatment with G-CSF.

Griva M, Lagoudaki R, Touloumi O, Nousiopoulou E, Karalis F, Georgiou T, Kokaraki G, Simeonidou C, Tata DA, Spandou E.

Brain Res. 2017 Jul 15;1667:55-67. doi: 10.1016/j.brainres.2017.05.004. Epub 2017 May 8.

PMID:
28495306
11.

Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemia.

Jellema RK, Lima Passos V, Ophelders DR, Wolfs TG, Zwanenburg A, De Munter S, Nikiforou M, Collins JJ, Kuypers E, Bos GM, Steinbusch HW, Vanderlocht J, Andriessen P, Germeraad WT, Kramer BW.

Exp Neurol. 2013 Dec;250:293-303. doi: 10.1016/j.expneurol.2013.09.026. Epub 2013 Oct 8.

PMID:
24120465
13.

Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.

Keller M, Simbruner G, Górna A, Urbanek M, Tinhofer I, Griesmaier E, Sarkozy G, Schwendimann L, Gressens P.

Pediatr Res. 2006 Apr;59(4 Pt 1):549-53.

PMID:
16549527
14.

Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans.

Begley CG, Basser R, Mansfield R, Thomson B, Parker WR, Layton J, To B, Cebon J, Sheridan WP, Fox RM, Green MD.

Blood. 1997 Nov 1;90(9):3378-89.

15.

[Mobilization effects of SCF along with G-CSF on bone marrow stem cells and endothelial progenitor cells in rats with unilateral ureteral obstruction].

Zhang JJ, Yi ZW, Dang XQ, He XJ, Wu XC.

Zhongguo Dang Dai Er Ke Za Zhi. 2007 Apr;9(2):144-8. Chinese.

PMID:
17448311
16.

Systemic G-CSF treatment does not improve long-term outcomes after neonatal hypoxic-ischaemic brain injury.

Schlager GW, Griesmaier E, Wegleiter K, Neubauer V, Urbanek M, Kiechl-Kohlendorfer U, Felderhoff-Mueser U, Keller M.

Exp Neurol. 2011 Jul;230(1):67-74. doi: 10.1016/j.expneurol.2010.11.021. Epub 2010 Dec 9.

PMID:
21145889
17.

Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats.

Zhao LR, Berra HH, Duan WM, Singhal S, Mehta J, Apkarian AV, Kessler JA.

Stroke. 2007 Oct;38(10):2804-11. Epub 2007 Aug 30.

PMID:
17761920
18.

Granulocyte-colony stimulating factor activates JAK2/PI3K/PDE3B pathway to inhibit corticosterone synthesis in a neonatal hypoxic-ischemic brain injury rat model.

Charles MS, Drunalini Perera PN, Doycheva DM, Tang J.

Exp Neurol. 2015 Oct;272:152-9. doi: 10.1016/j.expneurol.2015.03.019. Epub 2015 Mar 25.

20.

Brain repair by hematopoietic growth factors in a rat model of stroke.

Zhao LR, Singhal S, Duan WM, Mehta J, Kessler JA.

Stroke. 2007 Sep;38(9):2584-91. Epub 2007 Jul 26.

PMID:
17656664

Supplemental Content

Support Center